Your browser doesn't support javascript.
loading
Meropenem dosing recommendations for critically ill patients receiving continuous renal replacement therapy.
Chaijamorn, Weerachai; Rungkitwattanakul, Dhakrit; Pattharachayakul, Sutthiporn; Singhan, Wanchana; Charoensareerat, Taniya; Srisawat, Nattachai.
Affiliation
  • Chaijamorn W; Faculty of Pharmacy, Siam University, Bangkok, Thailand. Electronic address: weerachai.cha@siam.edu.
  • Rungkitwattanakul D; Department of Clinical and Administrative Pharmacy and Sciences Howard University College of Pharmacy, Washington, DC, USA.
  • Pattharachayakul S; Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Songkhla, Thailand.
  • Singhan W; Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.
  • Charoensareerat T; Faculty of Pharmacy, Siam University, Bangkok, Thailand.
  • Srisawat N; Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, and King Chulalongkorn Memorial Hospital, Bangkok, Thailand; Excellence Center for Critical Care Nephrology, King Chulalongkorn Memorial Hospital, Bangkok, Thailand; Critical Care Nephrology Research Unit,
J Crit Care ; 60: 285-289, 2020 12.
Article in En | MEDLINE | ID: mdl-32949895

Full text: 1 Database: MEDLINE Main subject: Critical Care / Acute Kidney Injury / Meropenem / Continuous Renal Replacement Therapy / Anti-Bacterial Agents Type of study: Guideline / Health_economic_evaluation / Observational_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2020 Type: Article

Full text: 1 Database: MEDLINE Main subject: Critical Care / Acute Kidney Injury / Meropenem / Continuous Renal Replacement Therapy / Anti-Bacterial Agents Type of study: Guideline / Health_economic_evaluation / Observational_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2020 Type: Article